Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-response and safety study of ferric citrate hydrate (JTT-751) in iron deficiency anemia
jRCT2080223256Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in iron deficiency anemia (IDA) comparing JTT-751 (ferric citrate hydrate) with Placebo (2 arms). Started Jul 2016; status: completed.
02
Drugs
ferric citrate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on jRCT2080223256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223256.